4//SEC Filing
Fenton Mary Kay 4
Accession 0000950170-25-025027
CIK 0001789972other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 6:00 PM ET
Size
7.2 KB
Accession
0000950170-25-025027
Insider Transaction Report
Form 4
Fenton Mary Kay
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-19+120,000→ 120,000 totalExercise: $9.43Exp: 2035-02-19→ Common Stock (120,000 underlying) - Award
Common Stock
2025-02-19+60,000→ 60,000 total
Footnotes (2)
- [F1]The shares underlying the restricted stock unit vest on an annual basis over four years.
- [F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
Documents
Issuer
Cullinan Therapeutics, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001378589
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 6:00 PM ET
- Size
- 7.2 KB